2019

 

  • Bachtiar V, Kelly MD, Wilman HR, Jacobs J, Newbould R, Kelly CJ, Gyngell ML, Groves KE, McKay A, Herlihy AH, Fernandes CC, Halberstadt M, Maguire M, Jayaratne N, Linden S, Neubauer S, Banerjee R. Repeatability and reproducibility of multiparametric magnetic resonance imaging of the liver. PLoS One. 2019 Apr 10;14(4):e0214921
  • So PW, Ekonomou A, Galley K, Brody L, Sahuri-Arisoylu M, Rattray I, Cash D, Bell JD. Intraperitoneal delivery of acetate-encapsulated liposomal nanoparticles for neuroprotection of the penumbra in a rat model of ischemic stroke. Int J Nanomedicine. 2019 Mar 18;14:1979–1991.
  • Mojtahed A, Kelly CJ, Herlihy AH, Kin S, Wilman HR, McKay A, Kelly M, Milanesi M, Neubauer S, Thomas EL, Bell JD, Banerjee R, Harisinghani M. Reference range of liver corrected T1 values in a population at low risk for fatty liver disease – a UK Biobank sub-study, with an appendix of interesting cases. Abdom. Radiol. (NY). 2019 Jan;44(1):72-84.
  • Kosgodage US, Uysal-Onganer P, MacLatchy A, Kraev I, Chatterton NP, Nicholas AP, Inal JM, Lange S. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme. Int J Mol Sci. 2018 Dec 28;20(1). pii: E103. 
  • Ji Y, Yiorkas AM, Frau F, Mook-Kanamori D, Staiger H, Thomas EL, Atabaki-Pasdar N, Campbell A, Tyrrell J, Jones SE, Beaumont RN, Wood AR, Tuke MA, Ruth KS, Mahajan A, Murray A, Freathy RM, Weedon MN, Hattersley AT, Hayward C, Machann J, Häring H-U, Franks P, de Mutsert R, Pearson E, Stefan N, Frayling TM, Allebrandt KV, Bell JD, Blakemore AI, Yaghootkar H. Genome-wide and abdominal MRI-imaging data provides evidence that a genetically determined favourable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease and hypertension. Diabetes 2019; 68(1): 207-219.
  • Chambers ES, Byrne CS, Rugyendo A, Morrison DJ, Preston T, Tedford MC, Bell JD, Thomas EL, Akbar AN, Riddell NE, Sharma R, Thursz MR, Manousou P and Frost G. The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease.  Diabetes, Obes. Metab. 2019; 21(2): 372–376.
  • Kosgodage US, Uysal-Onganer P, MacLatchy A, Kraev I, Chatterton NP, Nicholas AP, Inal JM, Lange S. Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme. Int J Mol Sci. 2019; 20(1). pii: E103. 
  • Kosgodage US, Uysal-Onganer P, MacLatchy A, Mould R, Nunn AV, Guy GW, Kraev I, Chatterton NP, Thomas EL, Inal JM, Bell JD, Lange S. Cannabidiol affects Extracellular Vesicle release, miR21 and miR126, and reduces Prohibitin Protein in Glioblastoma Multiforme Cells. Transl Oncol. 2019; 12(3): 513–522.

2018

 

  • McKay A, Wilman HR, Dennis A, Kelly M, Gyngell ML, Neubauer S, Bell JD, Banerjee R and Thomas EL. Measurement of liver iron by magnetic resonance imaging in the UK Biobank population. PLOS One 2018 Dec 21;13(12):e0209340.
  • Mole DJ, Fallowfield JA, Kendall TJ, Welsh F, Semple SI, Bachtiar V, Kelly M, Wigmore SJ, James Garden O, Wilman HR, Banerjee R, Rees M, Brady M. BMC Cancer. Study protocol: HepaT1ca - an observational clinical cohort study to quantify liver health in surgical candidates for liver malignancies. 2018 Sep 12;18(1):890.
  • Buckley A, Thomas EL, Lessan N, Trovato FM, Trovato GM and Taylor-Robinson SD. Non-alcoholic fatty liver disease: relationship with cardiovascular risk markers and clinical endpoints. Diabetes Res. Clin. Pract. 2018; 144: 144–154.
  • Kosgodage US, Uysal-Onganer P, MacLatchy A, Mould R, Nunn AV, Guy GW, Kraev I, Chatterton NP, Thomas EL, Inal JM, Bell JD, Lange S. Cannabidiol affects Extracellular Vesicle release, miR21 and miR126, and reduces Prohibitin Protein in Glioblastoma Multiforme Cells. Transl Oncol. 2018 Dec 28;12(3):513–522.
  • Chambers ES, Byrne CS, Rugyendo A, Morrison DJ, Preston T, Tedford MC, Bell JD, Thomas EL, Akbar AN, Riddell NE, Sharma R, Thursz MR, Manousou P and Frost G. The effects of dietary supplementation with inulin and inulin-propionate ester on hepatic steatosis in adults with non-alcoholic fatty liver disease. Diabetes, Obes. Metab. Aug 2018. In Press.
  • Buckley A, Thomas EL, Lessan N, Trovato FM, Trovato GM and Taylor-Robinson SD. Non-alcoholic fatty liver disease: relationship with cardiovascular risk markers and clinical endpoints. Diabetes Res. Clin. Pract. 2018; 144: 144–154.
  • Kosgodage US, Mould R, Henley AB, Nunn AV, Guy GW, Thomas EL, Inal JM, Bell JD, Lange S. Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer. Front. Pharmacol. 2018; 9: 889.
  • Linge J, Borger M, West J, Tuthill T, Miller MR, Dumitriu A, Thomas EL, Romu T, Tunón P, Bell JD, Leinhard OD. Body composition profiling in the UK Biobank imaging study. Obesity (Silver Spring). 2018; 26(11): 1785–1795.
  • Borga M, West J, Bell JD, Harvey NC, Romu T, Heymsfield SB, Dahlqvist Leinhard O. Advanced body composition assessment: from body mass index to body composition profiling. J Investig Med. 2018; 66(5):1–9.
  • Fiamoncini J, Rundle M, Gibbons H, Thomas EL, Geillinger-Kästle K, Bunzel D, Trezzi JP, Kiselova-Kaneva Y, Wopereis S, Wahrheit J, Kulling SE, Hiller K, Sonntag D, Ivanova D, van Ommen B, Frost G, Brennan L, Bell J, Daniel H. Plasma metabolome analysis identifies distinct human metabotypes in the postprandial state with different susceptibility to weight loss-mediated metabolic improvements. FASEB J. 2018; 32(10): 5447–5458
  • Shafique M, Russell S, Murdoch S, Bell JD, Guess N. Dietary intake in people consuming a low-carbohydrate diet in the UK Biobank. J Hum Nutr Diet. 2018; 31(2): 228–238
  • Cobbold JFL, Atkinson S, Marchesi JR, Smith A, Wai SN, Stove J, Shojaee-Moradie F, Jackson N, Umpleby AM, Fitzpatrick J, Thomas EL, Bell JD, Holmes E, Taylor-Robinson SD, Goldin RD, Yee MS, Anstee QM, Thursz MR. Rifaximin in non-alcoholic steatohepatitis: an open-label pilot study. Hepatol. Res. 2018; 48(1): 69–77.

2017

 

  • Umpleby AM, Shojaee-Moradie F, Fielding B, Li X, Marino A, Alsini N, Isherwood C, Jackson N, Ahmad A, Stolinski M, Lovegrove JA, Johnsen S, Mendis A, Wright J, Wilinska ME, Hovorka R, Bell JD, Thomas EL, Frost GS, Griffin BA. Impact of liver fat on the differential partitioning of hepatic triacylglycerol into VLDL subclasses on high and low sugar diets. Clin. Sci. 2017; 131(21): 2561–2573.
  • Brody LP, Sahuri Arisoylu M, Parkinson JR, Parkes HG, So PW, Hajji N, Thomas EL, Frost GS, Miller AD and Bell JD. Cationic lipid-based nanoparticles mediate functional delivery of acetate to tumor cells in vivo leading to significant anticancer effects. Int. J. Nanomed. 2017; 12: 6677–6685.
  • Villarini B, Asaturyan H, Thomas EL, Mould R, Bell JD. A framework for morphological feature extraction of organs from MR images for detection and classification of abnormalities. Proceedings of the 2017 IEEE 30th International Symposium on Computer-Based Medical Systems, CBMS 2017, Thessaloniki, Greece, 22-24 June 2017. 666–671.
  • Wilman HR, Kelly M, Garratt S, Matthews PM, Milanesi M, Herlihy A, Gyngell M, Neubauer S, Bell JD, Banerjee R, Thomas EL. Characterisation of liver fat in the UK Biobank cohort. PLoS One. 2017; 12(2): e0172921.
  • Shao A, Drewnowski A, Willcox DC, Krämer L, Lausted C, Eggersdorfer M, Mathers J, Bell JD, Randolph RK, Witkamp R, Griffiths JC. Optimal nutrition and the ever-changing dietary landscape: a conference report. Eur J Nutr. 2017; 56(Suppl 1): 1–21
  • Fitzpatrick J, Chambers E, Parkinson JRC, Mould R, Frost G, Bell JD, Thomas EL. Psoas major cross sectional area: a potential marker of cardiorespiratory fitness. Int. J. Clin. Experiment. Physiol. 2017; 4(1): 15–20.
  • Henley AB, Yang L, Chuang KL, Sahuri-Arisoylu M, Wu LH, Bligh SW, Bell JD. Withania somnifera Root Extract Enhances Chemotherapy through 'Priming'. PLoS One. 2017; 12(1): e0170917
  • Schofield SE, Parkinson JR, Henley AB, Sahuri-Arisoylu M, Sanchez-Canon GJ, Bell JD. Metabolic dysfunction following weight cycling in male mice. Int J Obes (Lond). 2017; 41(3): 402–411.